Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qu-Shi-Jie-Du decoction (QSJDD) is a traditional Chinese herbal formula developed by Professor Haibo Zhang. It is being investigated as an adjunctive therapy to prevent recurrence and metastasis in high-risk stage II/III colon cancer patients after surgery and chemotherapy. Preliminary studies suggest it may reduce liver metastasis. Its proposed mechanisms include boosting immunity, reducing inflammation, inhibiting tumor growth, and modulating various signaling pathways. The decoction is also believed to boost spleen Qi and remove dampness, according to Traditional Chinese Medicine principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qu-Shi-Jie-Du decoction.